Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Ivana Spasevska, Sarah Josefsson, PhD MSc, Yngvild Nuvin Blaker, MD PhD, Chloe B. Steen, PhD, Ankush Sharma, PhD, Kushi Kushekhar, PhD MSc, Saskia Meyer, PhD, Arne Kolstad, MD PhD, Klaus Beiske, MD PhD, Harald Holte, MD PhD, Bjørn Østenstad, MD PhD, Eva Kimby, MD PhD, Johanna Olweus, PhD, Kjetil Tasken, PhD, Suzanne Lorenz, PhD, Erlend B. Smeland, PhD MD, Ash A. Alizadeh, MD PhD, Kanutte Huse, PhD, June Helen Myklebust, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-142380

Published: 2020

Journal Articles

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Baoyan Bai, PhD, Daniel Vodák, BS, Sigve Nakken, PhD, Jillian F. Wise, PhD, Yngvild Nuvin Blaker, MD PhD, Ole Christian Lingjærde, PhD, Marianne Brodtkorb, MD PhD, Vera Hilden, Gunhild Trøen, Suzanne Lorenz, PhD, Michael S. Lawrence, PhD, Ola Myklebost, PhD, Leonardo Meza-Zepeda, PhD, Klaus Beiske, MD PhD, Eivind Hovig, PhD, Erlend B. Smeland, MD PhD, Harald Holte, MD PhD, June Helen Myklebust, PhD

Blood (2019) 134 (Supplement_1): 20.

https://doi.org/10.1182/blood-2019-128403

Published: 2019

Journal Articles

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

Blood (2019) 134 (Supplement_1): 1497.

https://doi.org/10.1182/blood-2019-131072

Published: 2019

Journal Articles

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Kathrine T. Isaksen, MD, Klaus Beiske, MD PhD, Erlend B. Smeland, MD PhD, Judit Jørgensen, MD PhD, Marianne Brodtkorb, MD PhD, June Helen Myklebust, PhD, Mats Jerkeman, MD Professor, Leo Meriranta, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Sirpa Leppa, MD PhD, David W. Scott, MBChB, PhD, Harald Holte, MD PhD, Yngvild Nuvin Blaker, MD PhD

Blood (2019) 134 (Supplement_1): 1485.

https://doi.org/10.1182/blood-2019-121467

Published: 2019

Journal Articles

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

Sirpa Leppa, MD Prof, Judit Jørgensen, MD PhD, Leo Meriranta, MS, Klaus Beiske, MD PhD, Jan M.A. Delabie, MD PhD, Elisabeth Ralfkiaer, MD DMSC, Signe Spetalen, MD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Harald Holte, MD PhD

Blood (2018) 132 (Supplement 1): 2955.

https://doi.org/10.1182/blood-2018-99-120057

Published: 2018

Journal Articles

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Jillian Frances Wise, PhD, Sigve Nakken, PhD, Daniel Vodak, BS, Gunhild Trøen, PhD, Ole Christian Lingjærde, PhD, Leonardo A. Meza-Zepeda, PhD, Ola Myklebost, PhD, Klaus Beiske, MD PhD, June Helen Myklebust, PhD, Eivind Hovig, PhD, Erlend Smeland, MD PhD, Harald Holte, Jr., MD PhD

Blood (2015) 126 (23): 110.

https://doi.org/10.1182/blood.V126.23.110.110

Published: 2015

Journal Articles

Single Cell Analysis Of Protein Phosphorylation In Chronic Myeloid Leukemia Treated With Dasatinib, Eltrombopag, and Pegfilgrastim

Bjorn T Gjertsen, MD PhD, Stein E Gullaksen, MSc, Jorn Skavland, PhD, Mihaela Lucia Popa, VMD, Roald Lindas, MD, Randi Hovland, PhD, Klaus Beiske, MD, Henrik Hjorth-Hansen, MD, PhD, Emmet McCormack, PhD

Blood (2013) 122 (21): 1492.

https://doi.org/10.1182/blood.V122.21.1492.1492

Published: 2013

NARROW

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Single Cell Analysis Of Protein Phosphorylation In Chronic Myeloid Leukemia Treated With Dasatinib, Eltrombopag, and Pegfilgrastim

Email alerts

ASH Publications

American Society of Hematology

Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma

Mutational Dynamics and Evolutionary Divergence in DLBCL: A Call for Relapse Sampling

The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy

Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Single Cell Analysis Of Protein Phosphorylation In Chronic Myeloid Leukemia Treated With Dasatinib, Eltrombopag, and Pegfilgrastim

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only